Centre Mandates Periodic Renewal for ART and Surrogacy Clinics

The Union government has mandated periodic renewal of registration for assisted reproductive technology (ART) and surrogacy clinics, tightening oversight of one of India's fastest-growing healthcare segments. The change reframes registration as a continuing obligation rather than a one-time licence, with clinics now required to periodically demonstrate compliance. It is a modest-sounding administrative change, but one that speaks to a larger reckoning within a sector that has, for years, grown ahead of the rules meant to govern it.

What the new rule requires

According to reports, ART clinics will need to renew their registration every five years, while surrogacy clinics will face a shorter three-year cycle. The tighter timeline for surrogacy reflects the heightened ethical and welfare considerations that surround it. By building in regular checkpoints, the framework gives regulators recurring opportunities to verify standards, rather than relying on a single approval that could become outdated as a clinic's practices evolve.

The distinction in cycle length is itself telling. ART clinics, which largely deal with procedures such as IVF for couples using their own gametes, are treated as requiring review on a longer horizon. Surrogacy clinics, by contrast, involve a third party — the surrogate — whose health, consent and long-term wellbeing depend heavily on how rigorously a clinic adheres to protocol. A three-year cycle effectively acknowledges that the risks in surrogacy arrangements are more acute and more likely to shift over time, whether through staff turnover, changes in ownership, or drift in clinical practice that would otherwise go unchecked between a one-time registration and any future enforcement action.

Why oversight is being tightened

India's fertility sector has expanded rapidly, drawing couples from across the country and abroad. That growth has brought scrutiny of clinical standards, consent practices and the treatment of donors and surrogates, who are often in vulnerable positions. Periodic renewal is intended to strengthen compliance, bolster patient confidence and embed ethical safeguards into routine operations, ensuring that protections keep pace with the sector's scale.

This is, in effect, an admission that a one-time licensing model was never well suited to an industry defined by rapid growth and wide variation in facility quality. A single registration granted years ago tells regulators little about whether a clinic today still meets the standards it was originally certified against. Equipment ages, staff change, and commercial pressures can quietly erode the protocols that protect patients and surrogates alike. Recurring renewal cycles convert oversight from a static event into an ongoing relationship between regulator and clinic, which is a more realistic model for an industry where the stakes involve human reproduction, bodily autonomy and, in the case of surrogacy, the welfare of women who may have limited leverage in negotiating the terms of their participation.

What it means for clinics and patients

For clinics, the mandate means treating regulatory standing as an ongoing responsibility, maintaining records, infrastructure and protocols that can withstand periodic review. Non-compliance could put renewal, and the right to operate, at risk. This shifts the operating incentives within the sector: a clinic can no longer treat its initial registration as a fixed asset to be exploited indefinitely. Instead, continued eligibility to operate becomes contingent on sustained performance, which should, in principle, discourage the kind of corner-cutting that regulators are less likely to catch under a system reliant on a single upfront inspection.

For patients, donors and surrogates, the change promises clearer protections and a stronger basis for trust when making deeply personal medical decisions. Couples seeking fertility treatment, and the surrogates who carry pregnancies on their behalf, are typically not well positioned to independently assess a clinic's clinical competence or ethical standing. A functioning renewal system is meant to do that assessment on their behalf, providing a degree of assurance that would otherwise be very difficult for an individual patient or surrogate to obtain through their own enquiries.

Key elements of the mandate: ART clinics must renew registration every five years. Surrogacy clinics face a three-year renewal cycle. Registration becomes a continuing obligation, not a one-time licence. The aim is stronger compliance and ethical safeguards. Protections target vulnerable couples, donors and surrogates.

The test of implementation

"Clinics will have to treat registration as a continuing obligation, not a one-time licence, with patient confidence and ethical safeguards at the centre," according to a policy summary of the change. That framing captures the intent well, but intent and execution are two different things. As implementation begins, the test will be enforcement: whether renewal reviews are rigorous and consistent across states. If applied effectively, the measure could raise standards sector-wide and reassure the many families who turn to fertility care, while keeping the focus firmly on the welfare of those most exposed to risk.

A federal country with wide variation in administrative capacity across states faces an inherent challenge in applying any national mandate uniformly. A renewal cycle is only as meaningful as the inspection regime behind it. If reviews in some states amount to little more than paperwork submission, while others involve genuine site visits, interviews with staff, and scrutiny of consent and welfare records, the result will be an uneven sector where protections depend heavily on geography rather than on the substance of the rule itself. Given that surrogacy and ART clinics often serve patients travelling from other states or countries specifically because of gaps in oversight elsewhere, this unevenness could undermine the very purpose the mandate is meant to serve.

The NE Times View

Periodic renewal is sound regulation for a fertility industry that has grown faster than its safeguards, often at the expense of donors and surrogates with little bargaining power. The principle behind it is difficult to fault: recurring checkpoints are a more realistic way to govern a fast-moving, ethically sensitive sector than a single approval frozen in time. But a renewal mandate is only as good as the inspections behind it. Without trained regulators verifying compliance on the ground, this risks becoming another paperwork ritual that legitimises clinics rather than disciplining them.

The measure should therefore be read as a necessary but not sufficient step. Its ultimate value will depend on resourcing — whether states invest in trained inspectors, whether renewal reviews are conducted with genuine independence, and whether clinics that fail to meet standards are actually denied renewal rather than granted routine extensions. Absent that follow-through, the shift from one-time licensing to periodic renewal risks being a change in form without a corresponding change in substance, leaving the vulnerable parties this rule is meant to protect no better off than before.

Key takeaways

• ART clinics must renew registration every five years, while surrogacy clinics face a shorter three-year cycle reflecting heightened ethical concerns.
• Registration shifts from a one-time licence to a continuing obligation, giving regulators recurring opportunities to check standards.
• The change targets rising concerns over consent, clinical standards and the treatment of donors and surrogates in a fast-growing sector.
• Clinics must now maintain sustained compliance with records, infrastructure and protocols, rather than relying on an initial approval.
• The measure's success will hinge on rigorous, consistent enforcement across states rather than on the rule's existence alone.